Latest reported quarter: Q2, ended Jun 2026 · reported in EUR
This company reports in its own local currency, not U.S. dollars. Every figure below is labeled with its real currency, not automatically converted.
| Line item | 2026 Q2 (EUR) |
2026 Q1 (EUR) |
2025 ANNUAL (EUR) |
2025 Q4 (EUR) |
2025 Q3 (EUR) |
|---|---|---|---|---|---|
| Total Revenue as Reported | €2.60B | €2.10B | €9.63B | €2.72B | €2.44B |
| Total Operating Revenue | €2.60B | €2.10B | €9.63B | €2.72B | €2.44B |
| Operating Profit | €294.00M | €197.00M | €967.00M | €1.00M | €260.00M |
| Special Income (Charges) | €29.00M | -€1.00M | €210.00M | – | – |
| Dividend Per Share | €0.56 | €0.08 | €0.83 | €0.48 | €0.00 |
| Cost of Revenue | – | – | €1.12B | – | – |
| Gross Profit | – | – | €8.50B | – | – |
| Operating Expense | – | – | €7.54B | – | – |
| Selling and Admin Expenses | – | – | €2.64B | – | – |
| -General & Admin Expense | – | – | €2.64B | – | – |
| Depreciation & Amortization & Depletion | – | – | €490.00M | – | – |
| -Depreciation & Amortization | – | – | €490.00M | – | – |
| Other Operating Expenses | – | – | €4.41B | – | – |
| Net Non-Operating Interest Income (Expense) | – | – | -€455.00M | – | – |
| Non-Operating Interest Income | – | – | €147.00M | – | – |
| Non-Operating Interest Expense | – | – | €438.00M | – | – |
| Total Other Finance Costs | – | – | €164.00M | – | – |
| Other Income (Expense) | – | – | €558.00M | – | – |
| Gain on Sale of Security | – | – | €90.00M | – | – |
| Earnings from Equity Interest | – | – | €258.00M | – | – |
| -Less:Impairment of Capital Assets | – | – | €62.00M | – | – |
| -Gain on Sale Of Business | – | – | €272.00M | – | – |
| Pretax Profit | – | – | €1.07B | – | – |
| Tax | – | – | -€60.00M | – | – |
| Net Profit | – | – | €1.15B | – | – |
| Profit from Continuing Operations | – | – | €1.13B | – | – |
| Net Income from Discontinuous Operations | – | – | €20.00M | – | – |
| Minority Interests | – | – | €262.00M | – | – |
| Net Income to Parent Company | – | – | €888.00M | – | – |
| Net Income to Common Stockholders | – | – | €888.00M | – | – |
| Basic EPS | – | – | €1.24 | – | – |
| Diluted EPS | – | – | €1.24 | – | – |
| Line item | 2026 Q2 (EUR) |
2025 ANNUAL (EUR) |
2025 Q4 (EUR) |
2025 Q2 (EUR) |
2024 ANNUAL (EUR) |
|---|---|---|---|---|---|
| Total Assets | €27.22B | €27.42B | €27.42B | €26.56B | €29.00B |
| Total Current Assets | €6.81B | €7.31B | €7.31B | €5.64B | €7.67B |
| Cash and Cash Equivalents & Short-Term Investments | €3.86B | €4.24B | €4.24B | €2.84B | €4.81B |
| -Cash and Cash Equivalents | €3.86B | €4.24B | €4.24B | €2.84B | €4.81B |
| Receivables | €2.31B | €2.17B | €2.17B | €2.19B | €2.19B |
| -Accounts Receivable | €1.84B | €1.76B | €1.76B | €1.69B | €1.63B |
| -Taxes Receivable | €62.00M | €41.00M | €41.00M | €58.00M | €48.00M |
| -Other Receivables | €415.00M | €371.00M | €371.00M | €436.00M | €519.00M |
| Inventory | €595.00M | €540.00M | €540.00M | €494.00M | €492.00M |
| Restricted Cash | €12.00M | €29.00M | €29.00M | €18.00M | €18.00M |
| Total Non-Current Assets | €20.41B | €20.11B | €20.11B | €20.92B | €21.33B |
| Net PPE | €1.45B | €1.31B | €1.31B | €1.08B | €1.01B |
| -Gross PPE | €1.45B | €1.89B | €1.89B | €1.08B | €1.62B |
| Investments and Advances | €3.92B | €4.02B | €4.02B | €4.25B | €3.63B |
| -Long Term Equity Investment | €3.92B | €3.96B | €3.96B | €4.25B | €3.02B |
| Financial Assets | €367.00M | €366.00M | €366.00M | €339.00M | €221.00M |
| Non Current Accounts Receivables | €105.00M | €26.00M | €26.00M | €632.00M | €28.00M |
| Non-Current Note Receivables | €130.00M | €126.00M | €126.00M | €101.00M | €101.00M |
| Goodwill and Other Intangible Assets | €542.00M | €539.00M | €539.00M | €576.00M | €628.00M |
| -Goodwill | €419.00M | €412.00M | €412.00M | €443.00M | €500.00M |
| -Other Intangible Assets | €123.00M | €127.00M | €127.00M | €133.00M | €128.00M |
| Non-Current Deferred Assets | €956.00M | €958.00M | €958.00M | €1.11B | €1.16B |
| Other Non-Current Assets | €163.00M | €262.00M | €262.00M | €303.00M | €400.00M |
| Total Liabilities | €19.82B | €19.76B | €19.76B | €18.91B | €20.88B |
| Total Current Liabilities | €5.69B | €6.46B | €6.46B | €5.98B | €6.30B |
| Payables | €2.39B | €2.15B | €2.15B | €2.19B | €2.11B |
| -Accounts Payable | €1.82B | €1.80B | €1.80B | €1.71B | €1.78B |
| -Total Tax Payable | €38.00M | €221.00M | €221.00M | €58.00M | €256.00M |
| -Other Payable | €523.00M | €127.00M | €127.00M | €423.00M | €72.00M |
| Short-Term Debt and Capital Lease Obligation | €381.00M | €1.16B | €1.16B | €1.34B | €1.28B |
| -Current Debt | €288.00M | €1.07B | €1.07B | €1.22B | €1.20B |
| -Current Capital Lease Obligation | €93.00M | €86.00M | €86.00M | €120.00M | €80.00M |
| Current Provisions | €841.00M | €929.00M | €929.00M | €911.00M | €958.00M |
| Current Deferred Liabilities | €2.04B | €1.82B | €1.82B | €1.51B | €1.62B |
| Other Current Liabilities | €40.00M | €151.00M | €151.00M | €39.00M | €85.00M |
| Total Non-Current Liabilities | €14.14B | €13.29B | €13.29B | €12.93B | €14.58B |
| Long Term Accounts Payable and Other Payables | €1.16B | €1.11B | €1.11B | €1.17B | €1.28B |
| Long Term Debt and Capital Lease Obligation | €10.28B | €9.58B | €9.58B | €9.01B | €10.26B |
| -Long Term Debt | €10.04B | €9.36B | €9.36B | €8.89B | €10.09B |
| -Long Term Capital Lease Obligation | €240.00M | €219.00M | €219.00M | €114.00M | €165.00M |
| Derivative Product Liabilities | €139.00M | €129.00M | €129.00M | €82.00M | €71.00M |
| Non-Current Liabilities | €409.00M | €395.00M | €395.00M | €354.00M | €353.00M |
| Non-Current Deferred Liabilities | €2.15B | €2.08B | €2.08B | €2.32B | €2.61B |
| Employee Benefits | €4.00M | €4.00M | €4.00M | €4.00M | €4.00M |
| Total Equity | €7.40B | €7.67B | €7.67B | €7.65B | €8.12B |
| Stockholders' Equity | €5.72B | €5.91B | €5.91B | €5.90B | €6.08B |
| Capital Stock | €7.00M | €7.00M | €7.00M | €7.00M | €7.00M |
| -Common Stock | €7.00M | €7.00M | €7.00M | €7.00M | €7.00M |
| Additional Paid-In Capital | €4.32B | €4.32B | €4.32B | €4.32B | €4.32B |
| Retained Earnings | €2.61B | €2.79B | €2.79B | €2.75B | €2.54B |
| Less: Treasury Stock | €78.00M | €78.00M | €78.00M | €78.00M | €79.00M |
| Other Equity Interests | -€1.14B | -€1.12B | -€1.12B | -€1.10B | -€705.00M |
| Minority Interests | €1.67B | €1.76B | €1.76B | €1.76B | €2.05B |
| Prepaid Assets | – | €112.00M | €112.00M | – | €83.00M |
| Other Current Assets | – | €1.00M | €1.00M | – | €1.00M |
| -Accumulated Depreciation | – | -€584.00M | -€584.00M | – | -€605.00M |
| -Available for Sale Securities | – | €61.00M | €61.00M | – | €610.00M |
| Current Accrued Expenses | – | €252.00M | €252.00M | – | €254.00M |
| Line item | 2025 ANNUAL (EUR) |
2024 ANNUAL (EUR) |
2023 ANNUAL (EUR) |
2022 ANNUAL (EUR) |
2021 ANNUAL (EUR) |
|---|---|---|---|---|---|
| Operating Cash Flow | €1.93B | €1.29B | €1.26B | €1.00B | €810.00M |
| Net cash flow from continuing operations | €1.93B | €1.29B | €1.26B | €1.00B | €810.00M |
| Net Income from Continuing Operations | €888.00M | €3.24B | €341.00M | €188.00M | €1.20B |
| Gain/Loss from Continuing Operations | -€258.00M | -€238.00M | -€215.00M | -€165.00M | €178.00M |
| Depreciation & Depletion & Amortization | €490.00M | €441.00M | €401.00M | €299.00M | €270.00M |
| Deferred Tax | -€60.00M | €145.00M | €115.00M | €30.00M | -€9.00M |
| Other Non-Cash Items | €608.00M | -€37.00M | €384.00M | €525.00M | €444.00M |
| Change in Working Capital | €63.00M | -€220.00M | €118.00M | -€83.00M | -€249.00M |
| Net cash flow from investing | -€891.00M | €1.31B | -€425.00M | -€732.00M | €457.00M |
| Net Cash Flow from Continuing Investing Activities | -€891.00M | €1.31B | -€425.00M | -€732.00M | €457.00M |
| Net PPE Purchase and Sale | -€187.00M | -€226.00M | -€86.00M | -€95.00M | -€124.00M |
| Net Business Purchase and Sale | -€478.00M | €1.30B | -€214.00M | €82.00M | €1.62B |
| Net Other Investing Changes | €96.00M | €257.00M | -€42.00M | €43.00M | -€804.00M |
| Financing Cash Flow | -€1.48B | -€2.59B | -€1.31B | -€316.00M | -€2.22B |
| Net Cash Flow from Continuing Financing Activities | -€1.48B | -€2.59B | -€1.31B | -€316.00M | -€2.22B |
| Net Issuance Payments Of Debt | -€20.00M | -€611.00M | €130.00M | €470.00M | -€1.20B |
| Net Common Stock Issuance | -€501.00M | -€973.00M | -€114.00M | -€446.00M | -€432.00M |
| Cash Dividends Paid | -€156.00M | -€130.00M | -€136.00M | -€132.00M | -€31.00M |
| Net Other Financing Charges | -€351.00M | -€413.00M | -€753.00M | €121.00M | -€264.00M |
| Ending Cash Balance | €4.27B | €4.83B | €4.79B | €5.13B | €5.54B |
| Net Change in Cash | -€458.00M | -€20.00M | -€501.00M | -€123.00M | -€1.09B |
| Beginning Cash Balance | €4.83B | €4.79B | €5.13B | €5.54B | €6.53B |
| Effect of Exchange Rate Changes | -€99.00M | €59.00M | €160.00M | -€283.00M | €99.00M |
| Free Cash Flow | €1.74B | €1.07B | €1.18B | €907.00M | €686.00M |
No comments yet — be the first to weigh in on FER.